Yudong Cao, Hecheng Zhu, Quan Chen, Hailong Huang, Dongcheng Xie, Xuewen Li, . . . Jiahui Peng. (2022). Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma. Frontiers Media S.A..
Chicago Style (17th ed.) CitationYudong Cao, Hecheng Zhu, Quan Chen, Hailong Huang, Dongcheng Xie, Xuewen Li, Xingjun Jiang, Caiping Ren, and Jiahui Peng. Integrated Analysis of Inflammatory Response Subtype-related Signature to Predict Clinical Outcomes, Immune Status and Drug Targets in Lower-grade Glioma. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationYudong Cao, et al. Integrated Analysis of Inflammatory Response Subtype-related Signature to Predict Clinical Outcomes, Immune Status and Drug Targets in Lower-grade Glioma. Frontiers Media S.A., 2022.